Search

Tai Huynh Phones & Addresses

  • 1067 19Th St NE APT F, Hickory, NC 28601
  • Milpitas, CA
  • 6055 St Peters Church Rd, Conover, NC 28613 (828) 381-2545
  • San Jose, CA
  • Boone, NC
  • Catawba, NC

Professional Records

Medicine Doctors

Tai Huynh Photo 1

Tai A. Huynh

View page
Specialties:
Internal Medicine
Work:
BayCare Medical GroupBayCare Medical Group Hospitalists
3231 Mcmullen Booth Rd STE 551, Safety Harbor, FL 34695
(727) 725-6526 (phone), (727) 266-4931 (fax)
Education:
Medical School
Tufts University School of Medicine
Graduated: 2001
Languages:
English
Spanish
Description:
Dr. Huynh graduated from the Tufts University School of Medicine in 2001. He works in Safety Harbor, FL and specializes in Internal Medicine. Dr. Huynh is affiliated with Mease Countryside Hospital and Mease Dunedin Hospital.

Resumes

Resumes

Tai Huynh Photo 2

Tai Huynh

View page
Work:
Oregon Institute of Technology

2014 to 2000
Graduate Teaching Assistant

Oregon Institute of Technology

2013 to 2000
Testing Center Assistant

Oregon Institute of Technology

2013 to 2000
Library Assistant

Oregon Institute of Technology

2014 to 2014
Graduate Intern

Samsung Corp

2005 to 2007
Technician

Education:
Oregon Institute of Technology
2013 to 2000
Master in Renewable Energy

Oregon Institute of Technology
2011 to 2013
Bachelor in Renewable Energy

Tai Huynh Photo 3

Tai Huynh Fort Riley, KS

View page
Work:
U.S. ARMY

May 2012 to 2000
Human Resource Specialist

U.S. ARMY

Jan 2010 to May 2012
Information Technology Specialist

U.S. ARMY

Apr 2009 to Jan 2010
Human Resource Specialist

COMMERCIAL DETAILING SYSTEMS
San Jose, CA
May 2005 to Apr 2009
Administrative Assistant

Education:
DEVRY UNIVERSITY
Sacramento, CA
Jun 2012
BS in Technical Management

ADJUTANT GENERAL SCHOOL
Fort Jackson, SC
Feb 2010
Leadership Course

PROSPECT HIGH SCHOOL
Saratoga, CA
Nov 2009

CENTRAL MICHIGAN UNIVERSITY
Mount Pleasant, MI
MSA in Management

Tai Huynh Photo 4

Tai Huynh

View page
Work:
Myhome Systems Pty Ltd

Jul 2012 to Aug 2014
Accounts Assistant

Myhome Systems Pty Ltd

Jul 2013 to Jul 2014
Bookkeeper/Accountant

Monash-Oakleigh Legal Service

Feb 2012 to Jun 2012
Consumer Advocate - Internship

Monash University

Jan 2011 to Nov 2011
Election Campaign Officer, Switch Political Society

Education:
Monash University
Dec 2012
Bachelor of Commerce in Accounting and Finance

Business Records

Name / Title
Company / Classification
Phones & Addresses
Tai Huynh
Vice President
T & H MACHINE, INC
Tai M. Huynh
Principal
Huynh Tai
Nonclassifiable Establishments
3232 Spg Rd NE, Hickory, NC 28601
Tai Huynh
Principal
Tmk Enterprise
Business Services
1898 39 Ave, Oakland, CA 94601

Publications

Us Patents

Inhibitors Of Hedgehog Pathway

View page
US Patent:
8222263, Jul 17, 2012
Filed:
Mar 14, 2008
Appl. No.:
12/049225
Inventors:
Suleyman Bahceci - San Mateo CA, US
William Bajjalieh - San Francisco CA, US
Jeff Chen - San Francisco CA, US
Sergey Epshteyn - Fremont CA, US
Timothy Patrick Forsyth - Hayward CA, US
Tai Phat Huynh - New York NY, US
Byung Gyu Kim - San Mateo CA, US
James W. Leahy - San Leandro CA, US
Matthew Sangyup Lee - San Francisco CA, US
Gary L. Lewis - San Francisco CA, US
Morrison B. Mac - San Francisco CA, US
Grace Mann - San Mateo CA, US
Charles K. Marlowe - Emerald Hills CA, US
Brian Hugh Ridgway - Belmont CA, US
Joan C. Sangalang - Mountain View CA, US
Xian Shi - San Bruno CA, US
Craig Stacy Takeuchi - Burlingame CA, US
Yong Wang - Foster City CA, US
Assignee:
Exelixis Patent Company LLC - South San Francisco CA
International Classification:
A61K 31/517
A01N 43/54
US Classification:
51426621, 5142661, 5142641, 544276, 544283, 544286
Abstract:
The present invention is directed to a compound of Formula I.

4-Aryl-2-Amino-Pyrimidines Or 4-Aryl-2-Aminoalkyl-Pyrimidines As Jak-2 Modulators And Methods Of Use

View page
US Patent:
8440663, May 14, 2013
Filed:
Jan 30, 2007
Appl. No.:
11/992224
Inventors:
Grace Mann - San Mateo CA, US
Naing Aay - San Mateo CA, US
Arlyn Arcalas - South San Francisco CA, US
S. David Brown - San Carlos CA, US
Wai Ki Vicky Chan - San Francisco CA, US
Jeff Chen - San Francisco CA, US
Hongwang Du - Millbrae CA, US
Sergey Epshteyn - Fremont CA, US
Timothy Patrick Forsyth - Hayward CA, US
Adam A. Galan - Alameda CA, US
Tai Phat Huynh - New York City NY, US
Mohamed Abdulkader Ibrahim - Mountain View CA, US
Henry William Beecroft Johnson - San Bruno CA, US
Brian Kane - Lynchburg VA, US
Patrick Kearney - San Francisco CA, US
Byung Gyu Kim - San Mateo CA, US
Elena S. Koltun - Foster City CA, US
James W. Leahy - San Leandro CA, US
Matthew Sangyup Lee - San Bruno CA, US
Gary L. Lewis - San Francisco CA, US
Lisa E. Meyr - Seattle WA, US
Robin Tammie Noguchi - San Bruno CA, US
Michael Pack - San Francisco CA, US
Brian Hugh Ridgway - Belmont CA, US
Xian Shi - San Bruno CA, US
John Woolfrey - Los Altos CA, US
Peiwen Zhou - Palo Alto CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
A61K 31/535
C07D 239/24
C07D 401/10
C07D 413/10
US Classification:
5142358, 544323, 544324, 544333
Abstract:
This invention relates to certain pyrimidine derivative inhibitors of JAK-2, having Formula (I): wherein D, E, L, Z, R, R, R, and n1 are as defined in the specification, pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof.

Protein Kinase Modulators And Methods Of Use

View page
US Patent:
20060211709, Sep 21, 2006
Filed:
May 2, 2003
Appl. No.:
10/513081
Inventors:
Chris Buhr - Redwood City CA, US
Sunghoon Ma - Foster City CA, US
Zerom Tesfai - San Leandro CA, US
Longcheng Wang - South San Francisco CA, US
Erick Co - Redwood City CA, US
Sergey Epshteyn - Fremont CA, US
Abigail Kennedy - San Leandro CA, US
Baili Chen - Palo Alto CA, US
Larisa Dubenko - San Francisco CA, US
Neel Anand - Burlingame CA, US
Tsze Tsang - El Cerrito CA, US
John Nuss - Danville CA, US
Kenneth Rice - Mill Valley CA, US
Mohamed Ibrahim - Mountain View CA, US
Xian Shi - San Bruno CA, US
James Leahy - San Leandro CA, US
Jeff Chen - San Francisco CA, US
Lisa Dalrymple - San Francisco CA, US
Timothy Forsyth - Hayward CA, US
Tai Huynh - Oakland CA, US
Grace Mann - Brisbane CA, US
Larry Mann - Redwood City CA, US
Craig Takeuchi - Burlingame CA, US
International Classification:
A61K 31/497
C07D 403/02
US Classification:
514255050, 544405000
Abstract:
Substituted aryl 1,4-pyrazine derivatives and their use in treating anxiety disorders, depression and stress related disorders are disclosed.

Inhibitors Of The Hedgehog Pathway

View page
US Patent:
20120238570, Sep 20, 2012
Filed:
Jun 4, 2012
Appl. No.:
13/487559
Inventors:
Suleyman Bahceci - San Mateo CA, US
William Bajjalieh - San Francisco CA, US
Jeff Chen - San Francisco CA, US
Sergey Epshteyn - Fremont CA, US
Timothy Patrick Forsyth - Hayward CA, US
Tai Phat Huynh - New York NY, US
Byung Gyu Kim - San Mateo CA, US
James W. Leahy - San Leandro CA, US
Matthew Sangyup Lee - San Francisco CA, US
Gary L. Lewis - San Francisco CA, US
Morrison B. Mac - San Francisco CA, US
Grace Mann - San Mateo CA, US
Charles K. Marlowe - Emerald Hills CA, US
Brian Hugh Ridgway - Belmont CA, US
Joan C. Sangalang - Mountain View CA, US
Xian Shi - San Bruno CA, US
Craig Stacy Takeuchi - Burlingame CA, US
Yong Wang - Foster City CA, US
Assignee:
EXELIXIS PATENT COMPANY LLC - San Francisco CA
International Classification:
A61K 31/517
A61K 31/519
C07D 413/04
A61P 35/00
C07D 239/84
C07D 471/04
C07D 403/12
A61K 31/5377
C07D 239/70
US Classification:
5142345, 5142581, 51426411, 5142662, 51426622, 51426623, 5142664, 544119, 544253, 544279, 544284
Abstract:
The present invention is directed to a compound of Formula Ior a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Formula I to treat cancer.

Inhibitors Of The Hedgehog Pathway

View page
US Patent:
20120245139, Sep 27, 2012
Filed:
Jun 4, 2012
Appl. No.:
13/487594
Inventors:
Suleyman Bahceci - San Mateo CA, US
William Bajjalieh - San Francisco CA, US
Jeff Chen - San Francisco CA, US
Sergey Epshteyn - Fremont CA, US
Timothy Patrick Forsyth - Hayward CA, US
Tai Phat Huynh - New York NY, US
Byung Gyu Kim - San Mateo CA, US
James W. Leahy - San Leandro CA, US
Matthew Sangyup Lee - San Francisco CA, US
Gary L. Lewis - San Francisco CA, US
Morrison B. Mac - San Francisco CA, US
Grace Mann - San Mateo CA, US
Charles K. Marlowe - Emerald Hills CA, US
Brian Hugh Ridgway - Belmont CA, US
Joan C. Sangalang - Mountain View CA, US
Xian Shi - San Bruno CA, US
Craig Stacy Takeuchi - Burlingame CA, US
Yong Wang - Foster City CA, US
Assignee:
EXELIXIS PATENT COMPANY LLC - San Francisco CA
International Classification:
A61K 31/517
A61P 35/00
A61K 31/55
A61K 31/519
A61K 31/5377
A61K 31/553
US Classification:
51421018, 5142664, 5142662, 5142345, 51425217, 51426622, 51426621, 51426624, 51426623, 51421109, 51421706, 514249, 5142325, 51426411, 5142581
Abstract:
The present invention is directed to a compound of Formula Ior a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Formula I to treat cancer.

C-Met Modulators And Method Of Use

View page
US Patent:
20130252940, Sep 26, 2013
Filed:
May 7, 2013
Appl. No.:
13/888592
Inventors:
Diva Sze-ming Chan - Oakland CA, US
Jeff Chen - San Francisco CA, US
Timothy Patrick Forsyth - Hayward CA, US
Tai Phat Huynh - Oakland CA, US
Vasu Jammalamadaka - Pleasanton CA, US
Richard George Khoury - San Mateo CA, US
James William Leahy - San Leandro CA, US
Morrison B. Mac - San Francisco CA, US
Larry W. Mann - Richland MI, US
John M. Nuss - Danville CA, US
Jason Jevious Parks - Sacramento CA, US
Craig Stacy Takeuchi - Burlingame CA, US
Yong Wang - Foster City CA, US
Wei Xu - Danville CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
C07D 215/233
C07D 413/14
C07D 401/14
C07D 405/14
C07D 295/15
C07D 401/12
US Classification:
51421021, 435 15, 435375, 5142352, 51425505, 51426622, 514307, 514312, 544128, 544287, 544405, 546146, 546153
Abstract:
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate, and/or modulate kinase receptor, particularly c-Met, KDF, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.

C-Met Modulators And Methods Of Use

View page
US Patent:
20210253530, Aug 19, 2021
Filed:
Aug 28, 2017
Appl. No.:
15/688310
Inventors:
- Alameda CA, US
Diva Sze-Ming Chan - Oakland CA, US
Jeff Chen - Honolulu HI, US
Lisa Esther Dalrymple - Bothell WA, US
Timothy Patrick Forsyth - Hayward CA, US
Tai Phat Huynh - Oakland CA, US
Vasu Jammalamadaka - Pleasanton CA, US
Richard George Khoury - San Mateo CA, US
James William Leahy - Tampa FL, US
Morrison B. Mac - San Francisco CA, US
Grace Mann - San Mateo CA, US
Larry W. Mann - Richland MI, US
John M. Nuss - Danville CA, US
Jason Jevious Parks - Elk Grove CA, US
Craig Stacy Takeuchi - Kanagawa-ken, JP
Yong Wang - Foster City CA, US
Wei Xu - Danville CA, US
International Classification:
C07D 215/233
A61K 31/496
C07D 239/94
A61K 31/4725
C07D 239/88
C07D 405/14
A61K 31/5377
A61K 31/505
A61K 31/517
C07D 295/15
C07D 413/12
A61K 31/506
C07D 401/12
A61K 31/501
C07D 413/14
C07D 215/46
A61K 31/47
C12Q 1/48
A61K 31/4709
C07D 403/12
C07D 215/22
C07D 215/36
C07D 417/12
C07D 215/38
C07D 401/14
Abstract:
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate and/or modulate kinase receptor, particularly c-Met, KDR, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.

C-Met Modulators And Methods Of Use

View page
US Patent:
20200331860, Oct 22, 2020
Filed:
Jul 6, 2020
Appl. No.:
16/921542
Inventors:
- Alameda CA, US
Diva Sze-Ming Chan - Oakland CA, US
Jeff Chen - Honolulu HI, US
Lisa Esther Dalrymple - Bothell WA, US
Timothy Patrick Forsyth - Hayward CA, US
Tai Phat Huynh - Oakland CA, US
Vasu Jammalamadaka - Pleasanton CA, US
Richard George Khoury - San Mateo CA, US
James William Leahy - Tampa FL, US
Morrison B. Mac - San Francisco CA, US
Grace Mann - San Mateo CA, US
Larry W. Mann - Richland MI, US
John M. Nuss - Danville CA, US
Jason Jevious Parks - Elk Grove CA, US
Craig Stacy Takeuchi - Kanagawa-ken, JP
Yong Wang - Foster City CA, US
Wei Xu - Danville CA, US
International Classification:
C07D 215/233
A61K 31/47
A61K 31/4709
A61K 31/517
C07D 215/22
C07D 295/15
C07D 401/12
C07D 401/14
C07D 405/14
C07D 413/14
C07D 239/88
A61K 31/4725
A61K 31/496
A61K 31/501
A61K 31/505
A61K 31/506
A61K 31/5377
C07D 215/46
C07D 239/94
C07D 403/12
C07D 413/12
C07D 417/12
C12Q 1/48
C07D 215/36
C07D 215/38
Abstract:
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate and/or modulate kinase receptor, particularly c-Met, KDR, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.
Tai Minh Huynh from Hickory, NC, age ~68 Get Report